Market Outlook

By 2035, the U.S. Disposable Medical Devices Market is projected to reach approximately USD 470.64 billion, expanding at a CAGR of 10.80% during the forecast period 2026–2035. The market is estimated at USD 168.77 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

The historical market expanded from approximately USD 106.11 billion in 2021 to USD 150.29 billion in 2024, including an estimated USD 119.17 billion in 2022 and USD 133.83 billion in 2023. Growth during this period reflected normalization of surgical volumes following pandemic disruption, higher hospital consumption of infection-control products, stronger outpatient procedure activity, expanding chronic-disease management, increased use of preconfigured procedure kits, and greater emphasis on supply-chain resilience.

The U.S. disposable medical devices industry represents one of the most recurring-revenue-intensive areas of healthcare technology. Unlike capital equipment categories that depend on hospital budget cycles, disposable devices are consumed with individual procedures, patient encounters, diagnostic tests, infusions, wound-care episodes, dialysis sessions, respiratory interventions, and home-care activities. This creates a revenue model closely linked to healthcare utilization rather than only capital expenditure.

Market scope includes single-use and short-duration medical devices and supplies used for diagnosis, treatment, surgery, infection prevention, medication delivery, wound care, specimen collection, renal therapy, respiratory management, urological care, and general patient management. Major categories include syringes, needles, IV administration products, catheters, surgical drapes and gowns, procedure kits, wound dressings, specimen-collection products, respiratory circuits, dialysis consumables, PPE, disposable electrodes, blood-management products, suction products, drainage systems, and other patient-contact consumables. Durable capital equipment, reusable surgical instruments, pharmaceuticals, and general consumer hygiene products are excluded.

The strategic importance of disposables has increased because U.S. hospitals are evaluating products through total episode economics, not simply price per unit. A disposable device capable of reducing preparation time, preventing contamination, eliminating sterilization steps, reducing sharps injuries, standardizing procedure setup, lowering inventory complexity, or supporting outpatient migration can justify a premium even when its acquisition price is higher than a conventional alternative.

Hospitals are also becoming more selective. Procurement leaders are reducing unnecessary SKU proliferation, consolidating suppliers, introducing clinically preferred product formularies, and demanding stronger evidence around sterility assurance, material performance, supply continuity, packaging efficiency, waste generation, and product standardization. This is creating a market in which scale remains important, but differentiated device design and supply reliability increasingly determine competitive advantage.

The central outlook for 2026–2035 is therefore not simply rising unit consumption. The market will progressively shift toward safety-engineered, procedure-specific, preassembled, digitally traceable, home-compatible, environmentally improved, and workflow-efficient disposable products. Manufacturers capable of combining clinical utility with reliable domestic or diversified supply networks will be positioned to capture disproportionate value.

 

Introduction

According to the U.S. Disposable Medical Devices Market Report, disposable products have become foundational to virtually every major care pathway in the American healthcare system. They are consumed across operating rooms, emergency departments, intensive care units, inpatient wards, physician practices, ambulatory surgery centers, laboratories, dialysis facilities, infusion centers, dental practices, skilled nursing facilities, and patient homes.

The scale of U.S. healthcare infrastructure creates an exceptionally large recurring demand base. The country has more than 6,000 hospitals, approximately 907,000 staffed hospital beds, and more than 35 million hospital admissions annually. In addition, the number of Medicare-certified ambulatory surgery centers exceeded 6,400 by 2024. Each facility requires a continuous supply of sterile and nonsterile patient-care consumables, with product volumes driven by admissions, procedures, diagnostic activity, patient acuity, infection-control protocols, and clinical specialty mix.

Healthcare expenditure reinforces the size of the addressable opportunity. U.S. national health expenditures reached approximately USD 5.3 trillion in 2024, while hospital expenditures alone exceeded USD 1.63 trillion and physician and clinical services spending surpassed USD 1.10 trillion. Disposable devices capture only a portion of these expenditures, but their recurring use means that they represent one of the most operationally indispensable components of healthcare delivery.

The category has also become strategically relevant because healthcare-associated infections remain an important patient-safety concern. Recent national surveillance indicates that approximately one in 38 hospitalized patients may have at least one healthcare-associated infection on a given day. Disposable products cannot independently eliminate infection risk, but sterile single-use systems can reduce opportunities for cross-contamination and eliminate some of the variability associated with cleaning and reprocessing reusable devices.

Demographic and chronic-disease patterns provide another structural demand layer. More than 40 million Americans are estimated to have diabetes, approximately 35.5 million adults have chronic kidney disease, and more than 2 million new cancer diagnoses were expected in the United States in 2025. These patient populations generate sustained consumption of infusion products, blood-collection devices, syringes, needles, wound-care products, dialysis consumables, drainage products, enteral feeding accessories, specimen-collection systems, and home-care disposables.

Disposable device economics are also changing. Historically, procurement teams frequently viewed basic disposables as commodity items and concentrated on unit-price reduction. Leading health systems now differentiate between truly commoditized supplies and products that influence clinical labor, safety, throughput, infection prevention, medication accuracy, procedure standardization, and downstream utilization.

This shift is particularly important for suppliers. Companies that compete exclusively on price face significant exposure to group purchasing organization negotiations, private-label competition, import pricing, freight volatility, and hospital SKU rationalization. Companies that demonstrate measurable workflow or clinical value can defend stronger margins, particularly in safety-engineered infusion, specialty catheters, advanced wound care, procedural kits, minimally invasive accessories, diagnostic consumables, and home-based chronic-care products.

From 2026 through 2035, the market will increasingly be shaped by the intersection of clinical utilization, supply assurance, outpatient migration, home healthcare, environmental pressure, regulatory scrutiny, and hospital labor economics.

 

Key Market Drivers: What’s Fueling the U.S. Disposable Medical Devices Market Boom?

The first major driver is the enormous recurring utilization base within U.S. hospitals and outpatient facilities. More than 35 million hospital admissions annually generate demand for IV administration products, syringes, needles, patient-care kits, catheters, wound dressings, PPE, drainage systems, electrodes, specimen products, suction devices, respiratory supplies, and other consumables. Unlike capital medical equipment, many of these products must be replenished continuously, making utilization growth directly relevant to supplier revenue.

A second major driver is the continued emphasis on infection prevention. Even as U.S. healthcare-associated infection rates improve, infection control remains embedded in hospital quality measurement, reimbursement, accreditation, value analysis, and patient-safety programs. Single-use products can simplify sterility assurance by eliminating cleaning cycles between patients and reducing opportunities for cross-patient contamination. This is particularly important for critical and semicritical devices, procedure kits, sterile barriers, catheters, respiratory products, wound-care supplies, and invasive diagnostic accessories.

The third driver is the migration of procedures toward outpatient settings. The U.S. had approximately 6,436 ambulatory surgery centers in 2024, with the number continuing to increase as clinical technology enables more procedures to be performed without an inpatient stay. Cataract surgery, gastrointestinal endoscopy, pain procedures, orthopedics, cardiovascular interventions, urology, ENT procedures, and other specialties increasingly operate within ambulatory economics. ASCs generally have smaller inventories, limited sterile-processing capacity, and strong incentives to maximize room turnover, creating favorable conditions for standardized disposable kits and procedure-specific single-use products.

A fourth driver is chronic-disease prevalence. Approximately 40.1 million Americans were estimated to have diabetes, while more than 35 million adults live with chronic kidney disease. Diabetes supports demand for needles, lancets, syringes, wound-management products, glucose-related consumables, infusion products, and home-based supplies. Kidney disease creates substantial requirements for dialysis bloodlines, fistula needles, access products, fluid-management devices, dressings, and treatment consumables. Cancer treatment similarly generates recurring demand for infusion, vascular access, specimen collection, biopsy, protective apparel, drainage, and supportive-care disposables.

A fifth driver is home healthcare. Disposable medical-device consumption is increasingly shifting outside institutional environments as chronic patients receive wound care, diabetes management, enteral nutrition, ostomy care, continence management, respiratory support, infusion therapy, and monitoring at home. This changes product requirements. Devices must be easier for patients or caregivers to use, clearly packaged, compatible with direct-to-patient fulfillment, and supported by reliable replenishment.

A sixth driver is hospital labor economics. U.S. providers continue to manage nursing shortages, sterile-processing workload, procedure-room productivity, and clinical burnout. Preassembled procedure packs, preconnected tubing, closed systems, ready-to-use dressings, safety syringes, disposable sensors, and standardized kits reduce steps that clinicians would otherwise perform manually. Labor savings of even a few minutes per procedure can become financially significant across thousands of annual cases.

A seventh driver is supply-chain resilience. The pandemic permanently changed how health systems assess disposable-product sourcing. Hospitals increasingly evaluate country-of-origin concentration, raw-material availability, supplier redundancy, manufacturing quality, emergency stock requirements, distributor performance, and transportation risk. Regulatory scrutiny of imported syringes and other products has further demonstrated that low acquisition cost is insufficient if product quality or continuity is uncertain.

The final structural driver is the increasing importance of outpatient and home reimbursement pathways. As Medicare, commercial insurers, and integrated delivery systems redirect appropriate care toward lower-cost settings, manufacturers must design disposables around those environments. Products that support same-day discharge, reduce complications, simplify training, and enable patient self-management are likely to capture growing share.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in disposable medical devices is moving away from simple material substitution toward clinically engineered products that influence safety, workflow, and total procedure economics.

Safety-engineered injection and vascular-access devices remain a major innovation area. Retractable needles, passive needle shielding, closed IV systems, needleless connectors, low-dead-space syringes, anti-reflux connectors, and engineered catheter securement technologies are designed to reduce occupational exposure, medication loss, disconnections, and vascular-access complications. Hospitals increasingly evaluate these products through nursing workflow and safety outcomes rather than purchase price alone.

Procedure customization represents another major direction. Manufacturers and distributors are developing procedure-specific kits containing drapes, gowns, syringes, gauze, tubing, bowls, preparation products, dressings, and specialty components configured around individual procedures. Customized kits can reduce setup time, eliminate redundant SKUs, improve case-cart efficiency, simplify inventory management, and reduce the number of packages opened during surgery.

Advanced wound care is moving beyond conventional gauze toward disposable products capable of actively managing moisture, infection risk, exudate, pressure, and wound microenvironment. Silicone dressings, superabsorbent products, antimicrobial dressings, hydrofiber technologies, disposable negative-pressure wound systems, and specialty multilayer products are particularly relevant in diabetic wounds, pressure injuries, surgical wounds, and post-acute care.

Respiratory and anesthesia disposables are also becoming more sophisticated. Closed suction systems, antimicrobial breathing circuits, heat-and-moisture exchangers, specialized airway products, single-patient ventilation accessories, and compact disposable components are being optimized to simplify ICU and procedural workflows while addressing infection-control requirements.

Diagnostic consumables are gaining value as testing moves closer to the patient. Blood-collection systems, specimen containers, swabs, single-use cartridges, collection kits, disposable pipetting components, biopsy accessories, and point-of-care consumables increasingly support decentralized diagnostic pathways. The commercial attractiveness of these categories lies in their recurring utilization once an installed diagnostic platform establishes a customer base.

Manufacturers are also focusing on packaging and material engineering. Reduced package volume, lighter materials, peel-efficient sterile barriers, compact kit configurations, recyclable packaging components, and lower-material-use device designs can reduce logistics costs and environmental burden. Sustainability is becoming particularly important in health-system sourcing because single-use devices contribute materially to regulated and nonregulated healthcare waste.

The industry will not shift entirely from disposable to reusable products, however. Instead, U.S. hospitals are likely to develop more selective lifecycle strategies. High-risk products with complex cleaning requirements may continue moving toward single-use designs, while selected high-cost disposable devices may be evaluated for regulated third-party reprocessing when technically appropriate. Manufacturers therefore face a more sophisticated competitive question: whether single-use performance, safety, workflow savings, and infection prevention justify the full lifecycle cost.

Digital traceability will also influence the next innovation cycle. Unique device identification, barcode-enabled inventory control, RFID-enabled kits, automated expiry monitoring, and integration with operating-room supply systems can help hospitals identify product location, manage recalls, monitor utilization, reduce expired inventory, and calculate procedure-level supply costs.

The strongest disposable-device companies through 2035 will therefore be those that convert low-complexity consumables into workflow platforms—combining physical product design, procedure standardization, data visibility, supply reliability, and documented clinical-economic value.

 

Segmentation Insights

The U.S. Disposable Medical Devices Market is segmented on the basis of product category, application, end user, material type, and region.

 

By Product Category

Surgical and Procedure Disposables

Surgical and procedural disposables represent the largest product group and are estimated to account for approximately one-quarter of the 2025 market. The category includes surgical gowns, drapes, procedure kits, sterile covers, suction products, surgical sponges, tubing, single-use instruments, minimally invasive accessories, surgical electrodes, and associated products.

Demand is supported by inpatient surgery, hospital outpatient procedures, ambulatory surgery centers, emergency care, and office-based intervention. Growth is shifting toward customized procedure packs and differentiated single-use accessories that reduce setup complexity and support faster operating-room turnover.

Injection and Infusion Disposables

Injection and infusion products include needles, syringes, safety syringes, IV catheters, administration sets, extension sets, connectors, stopcocks, infusion accessories, and related medication-delivery products. This category represents an estimated USD 30 billion-plus U.S. market opportunity in 2025 under the report’s scope.

Demand is exceptionally recurring because these products are used across nearly every acute-care environment and many chronic-care pathways. Growth will increasingly favor needleless systems, closed-system designs, safety-engineered devices, prefilled configurations where relevant, and products compatible with home infusion.

Infection-Control and Protective Disposables

This category includes examination gloves, surgical gloves, masks, respirators, isolation gowns, disposable protective apparel, sterile barriers, caps, shoe covers, and selected infection-control consumables. Demand normalized from pandemic-era peaks but remains structurally above the pre-COVID procurement paradigm because hospitals have retained stronger preparedness practices and supply-resilience requirements.

Procurement is increasingly influenced by domestic availability, supplier diversification, material quality, fit and comfort, contractual security, and inventory resilience rather than purely spot-market pricing.

Diagnostic and Specimen-Collection Disposables

Diagnostic disposables include blood-collection tubes, lancets, specimen containers, swabs, sample-collection kits, laboratory consumables, biopsy accessories, point-of-care cartridges, disposable electrodes, and other patient-contact diagnostic products.

The segment benefits from high testing volumes, chronic-disease monitoring, oncology diagnostics, emergency medicine, point-of-care testing, and decentralized diagnostic workflows. Products connected to proprietary testing platforms can generate particularly attractive recurring revenue because utilization follows the installed instrument base.

Wound-Care Disposables

Wound-care products include gauze, bandages, surgical dressings, foam dressings, hydrocolloids, alginates, hydrofiber dressings, antimicrobial dressings, fixation products, disposable negative-pressure systems, and related accessories.

Demand is supported by surgery, diabetes, vascular disease, pressure injuries, trauma, and an aging population. Advanced wound-care products are gaining share because hospitals and post-acute providers increasingly evaluate healing time, dressing-change frequency, nursing labor, infection risk, and avoidance of readmissions alongside unit cost.

Respiratory, Anesthesia and Urological Disposables

This segment includes breathing circuits, oxygen-delivery products, masks, suction catheters, airway accessories, endotracheal-related consumables, urinary catheters, drainage bags, intermittent catheterization products, continence-management devices, and procedural urology disposables.

The segment has a substantial hospital demand base. Urinary catheter utilization alone remains widespread among hospitalized patients, while home urological care creates a growing recurring direct-to-patient opportunity.

Dialysis and Blood-Management Disposables

Dialysis bloodlines, dialyzers where included as disposable products, fistula needles, tubing, collection bags, blood-management sets, apheresis consumables, transfusion accessories, and related products create an important high-frequency utilization market.

Chronic kidney disease affecting more than 35 million U.S. adults gives this segment a large long-term patient funnel. Dialysis procedures are exceptionally consumable-intensive, meaning patient growth, treatment frequency, and shifts toward home dialysis can materially alter product demand.

 

By Application

Surgical and Perioperative Care

Surgical and perioperative care represents the largest application and is estimated to account for approximately 27% of 2025 market revenue. Disposable gowns, drapes, kits, tubing, suction products, needles, syringes, wound dressings, minimally invasive accessories, and patient-preparation products are consumed throughout the surgical episode.

Future growth will increasingly follow ambulatory surgery, minimally invasive intervention, standardized procedure kits, and technologies that improve room turnover.

Chronic Disease Management

Diabetes, renal disease, cancer, cardiovascular conditions, respiratory disease, ostomy management, and chronic wounds create recurring demand over months or years rather than during a single episode.

This makes chronic-care disposables strategically attractive because the market combines high patient numbers with repeat purchasing. Direct-to-patient fulfillment and home-based care will be particularly important through 2035.

Diagnostic and Testing Procedures

Disposable products are essential throughout blood collection, pathology, microbiology, molecular diagnostics, point-of-care testing, oncology diagnostics, and routine laboratory testing.

The shift toward earlier diagnosis and distributed testing environments supports collection devices and single-use cartridges that can simplify specimen handling while reducing contamination risk.

Infection Prevention and General Patient Care

This application includes protective apparel, gloves, masks, sterile barriers, patient-care kits, drainage systems, routine nursing disposables, and other products used to maintain safe clinical environments.

The category’s growth will be steadier than the extraordinary pandemic period, but infection-prevention protocols have structurally raised hospital expectations regarding availability and supply security.

Critical Care, Emergency and Respiratory Management

Intensive-care and emergency departments consume high volumes of suction products, respiratory circuits, vascular-access devices, infusion disposables, drainage systems, electrodes, airway products, blood-collection supplies, and emergency procedure kits.

Product reliability has particularly high economic value in this segment because device failure can disrupt time-sensitive care.

Renal and Urological Care

Renal and urological applications include dialysis consumables, urinary drainage, intermittent catheterization, fluid-management systems, access products, and associated patient-care supplies.

Growth is supported by chronic kidney disease, aging demographics, home dialysis initiatives, urinary disorders, and increased use of direct-to-patient distribution.

 

By End User

Hospitals and Health Systems

Hospitals represent approximately 52% of the U.S. market in 2025, equivalent to roughly USD 87.76 billion under the report’s market definition. Hospitals consume the widest range of disposable devices and remain the primary market for higher-acuity sterile products.

Large integrated delivery networks exert substantial negotiating leverage through value-analysis committees, group purchasing organizations, standardized formularies, systemwide contracting, and private-label programs. Vendors seeking premium pricing increasingly need to demonstrate measurable clinical or workflow differentiation.

Ambulatory Surgery Centers

ASCs represent one of the most strategically attractive end-user categories. With approximately 6,436 centers operating in 2024, the sector continues expanding as appropriate surgeries migrate away from inpatient hospitals.

ASCs strongly favor compact inventory, predictable product cost, standardized procedure packs, rapid turnover, and products that eliminate expensive reprocessing infrastructure.

Clinics and Physician Practices

Primary-care practices, specialty clinics, urgent-care facilities, infusion centers, wound-care centers, dialysis clinics, and office-based procedural sites consume substantial volumes of needles, syringes, dressings, diagnostic products, PPE, specimen products, catheterization devices, and minor-procedure supplies.

Fragmentation within this customer group creates an important role for distributors and digital procurement platforms.

Diagnostic and Laboratory Facilities

Clinical laboratories, pathology facilities, blood-collection centers, imaging-related procedural facilities, and diagnostic networks generate recurring demand for sample-collection devices, tubes, needles, biopsy accessories, pipetting and transfer products, protective products, and testing consumables.

Automation and standardized specimen handling will influence future product configuration.

Home Healthcare, Long-Term Care and Direct-to-Patient Channels

Home healthcare and long-term care represent one of the fastest-growing end-user opportunities. Diabetes products, ostomy supplies, wound-care dressings, urological products, enteral feeding supplies, respiratory disposables, and continence-management products are increasingly delivered directly to patients.

Commercial success in this segment depends not only on device design but also payer documentation, reimbursement eligibility, fulfillment accuracy, recurring-order management, patient education, and last-mile distribution.

 

By Material Type

Plastics and Medical-Grade Polymers

Plastics and polymers dominate disposable medical-device manufacturing and are estimated to represent close to half of 2025 market value. Polypropylene, polyethylene, PVC, polyurethane, polycarbonate, and other engineered polymers are used in syringes, tubing, catheters, containers, connectors, packaging, masks, and procedure products.

The segment faces increasing scrutiny over waste generation, but plastics remain difficult to replace where sterility, transparency, flexibility, chemical resistance, precision molding, and low manufacturing cost are required.

Nonwoven and Textile Materials

Nonwoven materials are central to surgical gowns, drapes, masks, protective apparel, wraps, wound products, absorbent materials, and procedure packs.

Future differentiation will involve barrier performance, breathability, fluid resistance, lighter material structures, and reduced environmental footprint.

Rubber and Elastomers

Natural and synthetic rubber, nitrile, silicone, thermoplastic elastomers, and related materials are used in gloves, seals, tubing components, catheters, connectors, and flexible patient-contact products.

Nitrile continues to hold strategic importance in examination gloves because of durability and allergy considerations compared with traditional latex products.

Paper, Cellulose and Absorbent Materials

Cellulose-based and paper materials are used in packaging, absorbent products, examination products, sterilization barriers, wipes, wound care, and selected procedure products.

Sustainability priorities could increase interest in renewable fiber-based solutions when functional and regulatory requirements can be maintained.

Metals, Composites and Other Materials

Needles, guide components, surgical blades, specialty single-use instruments, electrodes, and minimally invasive accessories rely on stainless steel, conductive materials, engineered composites, and multimaterial construction.

Although smaller by overall market volume, these products can generate higher value per unit because design precision and clinical functionality are more important than raw-material cost.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Disposable Medical Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand differs according to population size, hospital density, ambulatory procedure volumes, chronic-disease prevalence, Medicare exposure, healthcare-system concentration, home-care penetration, manufacturing footprint, logistics infrastructure, and provider adoption of premium single-use technologies.

The South is the largest regional market, while the West is projected to register the fastest growth through 2035. The Northeast remains particularly important for premium and specialty disposable technologies, while the Midwest provides a large, stable procedural base and significant manufacturing and distribution infrastructure.

South

The South represents approximately USD 64.13 billion in 2025, or roughly 38% of the national market. Under the forecast model, regional revenue could approach USD 181.20 billion by 2035, supported by population growth, hospital expansion, chronic-disease burden, Medicare utilization, surgical activity, and strong development of outpatient and home-care networks.

Texas is one of the most strategically important disposable medical-device markets in the country. Houston, Dallas–Fort Worth, Austin, and San Antonio support large hospital systems, academic centers, ambulatory networks, cancer programs, cardiovascular facilities, and rapidly growing suburban healthcare infrastructure. The state’s population scale gives manufacturers substantial opportunities across procedure disposables, infusion, diagnostics, wound care, urology, and home healthcare.

Florida represents another major demand center because of its large older population, extensive hospital and outpatient infrastructure, surgical volumes, chronic-disease burden, long-term care activity, and substantial Medicare population. Wound care, urological supplies, infusion disposables, respiratory products, surgical kits, and chronic-care products are particularly relevant.

North Carolina and Georgia are high-growth markets supported by population migration, expanding hospital networks, life-science investment, and growing metropolitan areas around Charlotte, Raleigh-Durham, Atlanta, and surrounding markets. Tennessee combines major healthcare-company headquarters with significant hospital and distribution infrastructure.

Virginia and Maryland support sophisticated provider networks, academic health systems, military and federal healthcare activity, and high-value procedural demand. South Carolina continues to attract healthcare and manufacturing investment, while Kentucky has a significant hospital, post-acute, and chronic-disease demand base.

Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia have elevated burdens of diabetes, cardiovascular disease, renal disease, and other chronic conditions, creating strong recurring need for wound-care, dialysis, vascular-access, diagnostic, and home-care consumables. Rural access limitations increase the importance of regional distributors and efficient inventory networks.

Delaware is smaller in absolute market value but benefits from its location within the Mid-Atlantic healthcare corridor and proximity to major health systems across Maryland, Pennsylvania, and New Jersey.

Overall, the South should remain the country’s largest disposable-device market because it combines population scale with increasing healthcare capacity. Suppliers with strong distribution footprints in Texas, Florida, Georgia, North Carolina, Tennessee, and the Mid-Atlantic portion of the region will have a meaningful logistical advantage.

West

The West represents approximately USD 38.82 billion in 2025 and could reach approximately USD 117.66 billion by 2035, implying an estimated regional CAGR of around 11.7%, the fastest among the four U.S. regions.

California accounts for the largest share. Its combination of population size, academic medical centers, integrated health systems, medtech innovation, ambulatory care, home healthcare, and strong adoption of advanced procedural technologies makes it one of the most valuable state markets nationally.

California health systems are also influential in sustainability-oriented procurement. Suppliers capable of reducing packaging, waste volume, transportation footprint, and unnecessary components while preserving sterile performance may find the state an important early-adoption market.

Arizona and Nevada are expected to record above-average growth because of population expansion and increasing retiree populations. Greater Phoenix, Tucson, Las Vegas, and Reno continue adding healthcare capacity, supporting surgical disposables, diagnostic products, chronic-care supplies, infusion devices, wound management, and urology.

Colorado and Utah combine rapidly growing populations with sophisticated integrated health systems and technology-oriented clinical environments. Washington and Oregon have strong health-system networks and are important markets for premium procedural devices, connected supply-chain management, and environmentally differentiated products.

New Mexico, Idaho, Montana, and Wyoming represent smaller absolute revenue pools but present meaningful opportunities in regional referral systems, rural healthcare, ambulatory treatment, chronic-care supplies, and direct-to-patient distribution.

Alaska and Hawaii require specialized logistics because of geographic isolation and transportation costs. Supply reliability, product shelf life, compact packaging, distributor inventory management, and emergency stock planning can be more commercially important in these states than minimal differences in acquisition price.

The West is therefore expected to gain national market share through 2035 as population growth, outpatient procedure migration, home healthcare, and innovation-oriented purchasing accelerate.

Northeast

The Northeast represents approximately USD 35.44 billion in 2025 and is projected to approach USD 93.19 billion by 2035. Although population growth is slower than in the South and West, the region has high healthcare expenditure per capita, dense hospital networks, advanced academic medicine, major surgical programs, and strong adoption of premium clinical technologies.

New York is the region’s largest state market, supported by its population, major metropolitan hospital systems, academic institutions, outpatient facilities, nursing facilities, oncology infrastructure, and broad procedural base.

Pennsylvania combines major academic centers in Philadelphia and Pittsburgh with extensive community hospital and post-acute networks. New Jersey has high provider density, substantial pharmaceutical and medical-device industry presence, and close commercial integration with the New York and Philadelphia healthcare markets.

Massachusetts is disproportionately influential relative to its population because of its world-class academic medical centers, life-science ecosystem, specialty hospitals, clinical research environment, and early adoption of differentiated medical technology. Manufacturers frequently gain valuable clinical validation from leading institutions in Boston before expanding nationally.

Connecticut has a mature health-system market and substantial outpatient activity. Rhode Island, New Hampshire, Vermont, and Maine are smaller state markets but provide opportunities across hospital consumables, long-term care, home healthcare, chronic-disease management, and regional distribution.

The Northeast should remain particularly attractive for premium disposable technologies that demonstrate strong clinical evidence, nursing-efficiency benefits, infection-control performance, or specialty-procedure value. Procurement standards can be demanding, however, and sophisticated health systems frequently use detailed value-analysis processes before allowing new products onto formularies.

Midwest

The Midwest accounts for approximately USD 30.38 billion in 2025 and could reach around USD 78.60 billion by 2035. The region is expected to grow more slowly than the South or West but offers a highly dependable demand base across hospital care, surgery, chronic disease, long-term care, and medical-product distribution.

Illinois is the largest regional market, supported by Chicago’s hospital networks, academic centers, outpatient facilities, laboratories, and extensive logistics infrastructure.

Ohio is strategically important because of its large provider base, major health systems, medical distribution infrastructure, and central geographic position. Michigan also represents a substantial hospital and chronic-care market, particularly across Detroit, Grand Rapids, and regional healthcare networks.

Minnesota has particular strategic relevance because of its deep medical-device ecosystem and sophisticated provider organizations. Wisconsin and Indiana provide strong hospital and outpatient procedure volumes and benefit from their central location within national medical-supply distribution networks.

Missouri supports substantial healthcare markets around St. Louis and Kansas City, while Iowa and Kansas provide stable regional demand across hospitals, physician practices, rural care, and chronic-disease management.

Nebraska, North Dakota, and South Dakota represent smaller absolute markets, but their geographic dispersion makes reliable distribution, regional inventory, telehealth-supported home care, and simplified disposable-device logistics especially important.

The Midwest will remain a strong market for suppliers able to combine competitive contracting with consistent product quality, clinical education, inventory availability, and dependable distributor relationships.

 

Key Market Players

The U.S. Disposable Medical Devices Competitive Landscape is highly fragmented by product category but moderately consolidated within large-scale distribution and broad medical-surgical portfolios. Procurement decisions are heavily influenced by national distributors, group purchasing organizations, integrated delivery networks, private-label strategies, and enterprise contracts.

Some of the most relevant companies participating in the U.S. disposable medical-device ecosystem include Medline Industries; Cardinal Health; Becton, Dickinson and Company; Baxter International; B. Braun; Terumo Corporation; Teleflex; ICU Medical; Solventum; Smith+Nephew; Convatec Group; Coloplast; Hollister Incorporated; Mölnlycke Health Care; Owens & Minor; Ansell; Avanos Medical; McKesson Corporation; Nipro Corporation; Fresenius Medical Care; Merit Medical Systems; Cook Medical; Boston Scientific; Johnson & Johnson MedTech; and Stryker.

Medline, Cardinal Health, McKesson, and Owens & Minor have substantial influence because distribution reach, private-label portfolios, hospital contracting, and inventory availability are critical in high-volume disposable categories.

BD, B. Braun, Baxter, ICU Medical, Teleflex, Terumo, Merit Medical, and Nipro compete strongly across injection, infusion, vascular access, blood management, catheterization, procedural, and other clinically differentiated consumables.

Smith+Nephew, Convatec, Solventum, Coloplast, Hollister, and Mölnlycke have strategically important positions in wound care, ostomy, continence management, skin care, infection prevention, and chronic-care disposables.

Johnson & Johnson MedTech, Boston Scientific, Cook Medical, Stryker, Avanos Medical, and other procedure-focused manufacturers generate recurring disposable revenue around surgical and interventional platforms.

Competitive advantage through 2035 will depend less on portfolio size alone and more on the ability to combine supply assurance, regulatory compliance, clinical differentiation, contracting flexibility, procedure economics, digital inventory support, and product lifecycle management.

Health systems are expected to continue consolidating suppliers where commoditization is high while selectively adopting premium products where measurable clinical or workflow value exists. This dynamic should favor scale players in basic consumables and specialized manufacturers in high-value procedural categories.

 

Recent Developments

Recent developments illustrate how quality assurance and supply resilience are reshaping the U.S. disposable-device market.

During 2024, FDA scrutiny of certain plastic syringes manufactured in China highlighted the operational and clinical risk associated with globalized sourcing. Concerns included leakage, breakage, dimensional variation, and medication-delivery performance. FDA actions involving manufacturers, import controls, distributors, and convenience kits forced many healthcare organizations to evaluate alternative suppliers and reinforced the strategic value of qualified manufacturing capacity outside a single country.

The episode had broader significance than the syringe category alone. Hospitals increasingly recognize that disposable products once treated as simple commodities can become critical bottlenecks when quality issues affect high-volume categories. Vendor qualification, country-of-origin visibility, manufacturing audits, secondary sourcing, and contractual continuity provisions are consequently becoming more important in purchasing decisions.

Medical-device shortages remain another strategic issue. FDA continues to maintain a formal device-shortage framework and has identified shortages affecting products including specialized needles and procedure-related disposable systems. The implication for manufacturers is clear: continuity of supply is becoming an element of product value.

Distribution is also evolving toward direct-to-patient healthcare. Cardinal Health expanded its at-home distribution footprint in Texas in 2025 with a 340,000-square-foot automated facility designed to support thousands of daily patient shipments and subsequently outlined further West Coast capacity expansion. Such investments illustrate how diabetes, urology, wound care, sleep therapy, and other chronic-care categories are creating a different supply-chain model from traditional hospital distribution.

Infection-prevention performance also continues to improve. Updated U.S. surveillance showed that healthcare-associated infections decreased across several monitored categories between 2023 and 2024. This does not reduce the importance of disposable devices. Instead, it raises the standard of evidence. Hospitals increasingly expect manufacturers to show how specific product design, catheter management, sterile technique, closed systems, or procedure standardization contributes to prevention rather than assuming that single-use status alone guarantees superior outcomes.

Environmental scrutiny is simultaneously intensifying. Disposable products reduce or eliminate reprocessing requirements but generate substantial material waste. Hospitals are therefore testing more selective strategies involving lighter materials, recyclable packaging, waste segregation, product redesign, procedure-pack optimization, and regulated reprocessing of appropriate single-use devices.

FDA regulation of reprocessed single-use devices creates an important commercial counterbalance. Products originally labeled for one patient or one procedure can only enter regulated reprocessing pathways when applicable safety, cleaning, disinfection, sterilization, functional-performance, labeling, and regulatory requirements are met. This means sustainability strategies cannot be separated from device performance and patient safety.

The competitive direction of the U.S. market is consequently becoming more sophisticated. Winning suppliers will not simply manufacture inexpensive disposables. They will be expected to provide safe products, documented quality, responsive recall capability, resilient sourcing, efficient packaging, clinical education, distribution visibility, and measurable economic value.

 

Conclusion

The U.S. Disposable Medical Devices Market Size & Share is positioned for substantial expansion from approximately USD 168.77 billion in 2025 to USD 470.64 billion by 2035, representing a 10.80% CAGR during 2026–2035.

The market’s growth profile is supported by unusually strong structural fundamentals: more than 35 million annual hospital admissions, over 6,400 ambulatory surgery centers, expanding outpatient treatment, high chronic-disease prevalence, continued infection-prevention requirements, growth in home healthcare, and the recurring consumption characteristics of single-use products.

Surgical and procedure disposables will remain a major revenue pool, but premium growth opportunities will emerge across safety-engineered injection products, advanced vascular access, customized procedure kits, specialty wound care, home urology, dialysis consumables, diagnostic cartridges, infection-control products, single-use minimally invasive accessories, and clinically differentiated respiratory devices.

Hospitals will remain the dominant end user, accounting for approximately 52% of the 2025 market, but the competitive center of gravity will gradually move toward ambulatory and home environments. Manufacturers will therefore need portfolios capable of operating across hospital purchasing systems, ASCs, physician practices, distributors, durable medical equipment suppliers, and direct-to-patient fulfillment networks.

Regionally, the South will remain the largest market, rising from approximately USD 64.13 billion in 2025 toward USD 181.20 billion by 2035. The West will be the fastest-growing region, driven by population expansion, outpatient care, technology adoption, and home healthcare. The Northeast will retain its importance for high-value and evidence-driven disposable technologies, while the Midwest will remain a stable procedural and distribution market.

Texas, Florida, California, New York, Pennsylvania, Illinois, Ohio, New Jersey, Massachusetts, North Carolina, Georgia, Arizona, Michigan, Minnesota, Tennessee, Virginia, Washington, and Colorado will be especially important commercially, while smaller and rural states will create distinct opportunities in direct distribution, chronic-care supplies, and resilient inventory networks.

Hospital procurement will become increasingly difficult for suppliers that rely purely on unit-price competition. Buyers are progressively evaluating disposable products through total cost per procedure, clinical labor, infection risk, preparation time, waste volume, supply continuity, standardization potential, and downstream patient outcomes.

At the same time, environmental considerations will prevent an unrestricted shift toward disposability. The next decade will involve a more selective balance among single-use devices, reusable systems, and regulated reprocessing. Disposable products will gain preference when they solve a meaningful infection-control, workflow, reliability, or clinical problem; reusable or reprocessed alternatives will remain relevant when their lifecycle economics are demonstrably superior.

For clients evaluating this market, the central strategic question is therefore not whether consumption of disposable medical devices will increase. The more important questions are which categories can sustain premium pricing, where procedures are migrating, which products meaningfully reduce clinical workload, how supply chains should be redesigned, and how manufacturers can reconcile single-use convenience with growing environmental expectations.

Companies capable of answering those questions through clinically differentiated products, resilient manufacturing, sophisticated distribution, strong regulatory execution, and quantified workflow economics are likely to define the next decade of the U.S. disposable medical devices industry.

 

TABLE OF CONTENT

1. U.S. Disposable Medical Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. In-Scope Disposable and Single-Use Medical Devices
1.2.2. Market Exclusions and Boundary Conditions
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up and Top-Down Market Sizing Framework
1.3.6. Utilization-Based Demand Modeling
1.3.7. Analytical Frameworks & Forecasting Models
1.3.8. Data Triangulation, Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Historical Period, Base Year and Forecast Period
1.6. Market Ecosystem Overview
1.7. Stakeholder Analysis
1.7.1. Disposable Medical Device Manufacturers
1.7.2. Raw Material, Component and Contract Manufacturing Suppliers
1.7.3. Sterilization and Packaging Service Providers
1.7.4. Hospitals and Integrated Delivery Networks
1.7.5. Ambulatory Surgery Centers and Outpatient Facilities
1.7.6. Physician Practices, Specialty Clinics and Diagnostic Laboratories
1.7.7. Home Healthcare and Long-Term Care Providers
1.7.8. Group Purchasing Organizations
1.7.9. National and Regional Medical-Surgical Distributors
1.7.10. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section establishes the market definition, report boundaries, research methodology, sizing assumptions, utilization framework, and stakeholder ecosystem used to measure and forecast the U.S. disposable medical devices market.

2. U.S. Disposable Medical Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Snapshot
2.8. Largest Revenue-Generating Product Categories
2.9. Fastest-Growing Product and Application Areas
2.10. End-User Demand Snapshot
2.11. Regional Opportunity Snapshot
2.12. High-Growth Opportunity Areas
2.13. Critical Success Factors for Market Participants

What this section provides: This section gives decision-makers a concise view of market size, CAGR, historical performance, growth outlook, segment leadership, demand concentration, competitive intensity, and priority investment opportunities.

3. U.S. Disposable Medical Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. High Recurring Consumption Across U.S. Healthcare Facilities
3.1.2. Rising Surgical and Procedural Volumes
3.1.3. Expansion of Ambulatory and Outpatient Procedures
3.1.4. Increasing Focus on Infection Prevention and Sterility Assurance
3.1.5. Rising Chronic Disease and Aging Population Burden
3.1.6. Growth of Home Healthcare and Direct-to-Patient Care
3.1.7. Clinical Workforce Shortages and Demand for Workflow-Efficient Products
3.1.8. Increasing Adoption of Preconfigured Procedure Packs and Kits
3.1.9. Demand for Supply-Chain Resilience and Product Availability

3.2. Restraints and Their Impact Analysis
3.2.1. Intense Price Competition in Commodity Disposable Categories
3.2.2. Hospital SKU Rationalization and GPO Pricing Pressure
3.2.3. Environmental Waste and Sustainability Concerns
3.2.4. Dependence on Global Raw Materials and Overseas Manufacturing
3.2.5. Product Quality, Recall and Sterility Risks
3.2.6. Reimbursement Constraints in Selected Home-Care Categories
3.2.7. Growing Evaluation of Reusable and Reprocessed Alternatives

3.3. Opportunities and Their Impact Analysis
3.3.1. Safety-Engineered Needles, Syringes and Vascular Access Devices
3.3.2. Customized Surgical and Procedure Packs
3.3.3. Advanced Disposable Wound-Care Technologies
3.3.4. Home-Based Chronic-Care and Patient Self-Management Products
3.3.5. Single-Use Minimally Invasive and Diagnostic Accessories
3.3.6. Environmentally Optimized Disposable Medical Devices
3.3.7. Domestic and Diversified Manufacturing Expansion
3.3.8. RFID, UDI and Digitally Traceable Consumables
3.3.9. Direct-to-Patient Distribution Models

3.4. Challenges and Their Impact Analysis
3.4.1. Maintaining Margin Amid High-Volume Contract Pricing
3.4.2. Balancing Disposable Convenience with Sustainability Requirements
3.4.3. Maintaining Sterility Across Complex Supply Networks
3.4.4. Raw Material and Transportation Volatility
3.4.5. Differentiating Products in Highly Commoditized Categories

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Procedure-Level Cost and Consumable Utilization Analysis
3.8. Hospital Consumables Procurement Behavior Analysis
3.9. Value Analysis Committee Decision-Making Analysis
3.10. ASC Workflow and Purchasing Economics Analysis
3.11. Home Healthcare Replenishment Economics

What this section provides: This section evaluates the clinical, demographic, operational, economic, supply-chain, and procurement forces influencing disposable medical device demand and identifies the principal commercial opportunities and execution risks through 2035.

4. U.S. Disposable Medical Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitution
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Raw Material Suppliers
4.4.2. Component Manufacturers
4.4.3. Device Manufacturing and Assembly
4.4.4. Sterilization and Packaging
4.4.5. National and Regional Distribution
4.4.6. Hospital and Outpatient Consumption
4.4.7. Home-Care Fulfillment
4.5. Raw Material Availability and Cost Analysis
4.6. Medical-Grade Polymer and Nonwoven Supply Analysis
4.7. Sterilization Capacity and Packaging Landscape
4.8. Digitalization, UDI and Inventory Automation
4.9. Application & Innovation Landscape
4.10. FDA Regulatory Framework Analysis
4.10.1. Device Classification and Premarket Requirements
4.10.2. Quality System Requirements
4.10.3. Sterility and Packaging Requirements
4.10.4. Medical Device Reporting and Recall Requirements
4.10.5. Reprocessed Single-Use Device Regulatory Considerations
4.11. CMS Reimbursement and Coverage Landscape
4.12. Import/Export Restrictions & Tariff Impact
4.13. Domestic Manufacturing and Supply-Security Initiatives
4.14. Government Healthcare Preparedness Programs
4.15. Environmental Sustainability and Medical Waste Landscape
4.16. Impact of Escalating Geopolitical Tensions
4.17. Hospital Value Analysis Committee Decision Framework
4.18. GPO and IDN Contracting Environment

What this section provides: This section provides clients with a complete assessment of regulation, reimbursement, pricing, raw materials, manufacturing, sterilization, distribution, sustainability, supply-chain risk, digital traceability, and institutional procurement dynamics.

5. U.S. Disposable Medical Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)

5.1.2. Surgical and Procedure Disposables
5.1.2.1. Surgical Gowns and Drapes
5.1.2.2. Custom Procedure Packs and Surgical Kits
5.1.2.3. Disposable Surgical Instruments
5.1.2.4. Suction and Fluid-Management Products
5.1.2.5. Surgical Sponges and Absorbent Products
5.1.2.6. Minimally Invasive Procedure Accessories
5.1.2.7. Other Surgical Disposables

5.1.3. Injection and Infusion Disposables
5.1.3.1. Disposable Syringes
5.1.3.2. Hypodermic and Safety Needles
5.1.3.3. Peripheral IV Catheters
5.1.3.4. IV Administration Sets
5.1.3.5. Extension Sets and Stopcocks
5.1.3.6. Needleless Connectors
5.1.3.7. Infusion Accessories

5.1.4. Infection-Control and Protective Disposables
5.1.4.1. Examination Gloves
5.1.4.2. Surgical Gloves
5.1.4.3. Medical Masks and Respirators
5.1.4.4. Isolation Gowns
5.1.4.5. Disposable Protective Apparel
5.1.4.6. Sterile Barriers and Covers

5.1.5. Diagnostic and Specimen-Collection Disposables
5.1.5.1. Blood-Collection Tubes
5.1.5.2. Blood-Collection Needles and Lancets
5.1.5.3. Specimen Containers
5.1.5.4. Swabs and Collection Kits
5.1.5.5. Point-of-Care Testing Consumables
5.1.5.6. Disposable Electrodes
5.1.5.7. Biopsy and Diagnostic Procedure Accessories

5.1.6. Wound-Care Disposables
5.1.6.1. Traditional Dressings
5.1.6.2. Foam Dressings
5.1.6.3. Hydrocolloid Dressings
5.1.6.4. Alginate and Hydrofiber Dressings
5.1.6.5. Antimicrobial Dressings
5.1.6.6. Disposable Negative-Pressure Wound Therapy Products
5.1.6.7. Fixation and Securement Products

5.1.7. Respiratory and Anesthesia Disposables
5.1.7.1. Breathing Circuits
5.1.7.2. Oxygen Masks and Delivery Products
5.1.7.3. Suction Catheters
5.1.7.4. Airway Management Accessories
5.1.7.5. Heat and Moisture Exchange Products
5.1.7.6. Other Respiratory Consumables

5.1.8. Urological and Continence Disposables
5.1.8.1. Foley Catheters
5.1.8.2. Intermittent Catheters
5.1.8.3. Urinary Drainage Bags
5.1.8.4. External Urinary Management Products
5.1.8.5. Continence Care Products

5.1.9. Dialysis and Blood-Management Disposables
5.1.9.1. Dialysis Bloodlines and Tubing
5.1.9.2. Dialyzers
5.1.9.3. Fistula Needles
5.1.9.4. Blood-Collection and Storage Bags
5.1.9.5. Transfusion Sets
5.1.9.6. Apheresis Consumables

5.1.10. Other Disposable Medical Devices

What this section provides: This section identifies the disposable medical device categories contributing the largest revenue pools and evaluates which product groups are expected to experience the strongest volume, pricing, innovation, and recurring-consumption growth through 2035.

6. U.S. Disposable Medical Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)

6.1.2. Surgical and Perioperative Care
6.1.2.1. General Surgery
6.1.2.2. Orthopedic Surgery
6.1.2.3. Cardiovascular Procedures
6.1.2.4. Gastrointestinal Procedures
6.1.2.5. Urological Procedures
6.1.2.6. Gynecological Procedures
6.1.2.7. Ophthalmic and ENT Procedures

6.1.3. Chronic Disease Management
6.1.3.1. Diabetes Management
6.1.3.2. Chronic Kidney Disease and Dialysis
6.1.3.3. Cancer Care
6.1.3.4. Chronic Wound Management
6.1.3.5. Respiratory Disease Management
6.1.3.6. Ostomy and Continence Management

6.1.4. Diagnostic and Testing Procedures
6.1.4.1. Blood Collection
6.1.4.2. Clinical Laboratory Testing
6.1.4.3. Point-of-Care Testing
6.1.4.4. Microbiology and Infectious Disease Testing
6.1.4.5. Oncology and Pathology Diagnostics

6.1.5. Infection Prevention and General Patient Care
6.1.5.1. Hospital Infection Prevention
6.1.5.2. Barrier Protection
6.1.5.3. Routine Nursing Care
6.1.5.4. Isolation and Contact Precautions
6.1.5.5. General Patient Hygiene and Management

6.1.6. Critical Care, Emergency and Respiratory Management
6.1.6.1. Intensive Care
6.1.6.2. Emergency Medicine
6.1.6.3. Respiratory Therapy
6.1.6.4. Airway Management
6.1.6.5. Fluid and Medication Administration

6.1.7. Renal and Urological Care
6.1.7.1. Hemodialysis
6.1.7.2. Peritoneal Dialysis
6.1.7.3. Urinary Drainage
6.1.7.4. Intermittent Catheterization
6.1.7.5. Continence Management

What this section provides: This section explains disposable device demand by clinical application and helps clients identify the care pathways offering the strongest recurring utilization, procedure growth, chronic-care exposure, and product differentiation opportunities.

7. U.S. Disposable Medical Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)

7.1.2. Hospitals and Health Systems
7.1.2.1. Academic Medical Centers
7.1.2.2. Community Hospitals
7.1.2.3. Specialty Hospitals
7.1.2.4. Integrated Delivery Networks

7.1.3. Ambulatory Surgery Centers
7.1.3.1. Multispecialty ASCs
7.1.3.2. Single-Specialty ASCs
7.1.3.3. Hospital-Affiliated ASCs
7.1.3.4. Independent ASCs

7.1.4. Clinics and Physician Practices
7.1.4.1. Primary Care Practices
7.1.4.2. Specialty Physician Practices
7.1.4.3. Urgent Care Centers
7.1.4.4. Office-Based Procedure Centers

7.1.5. Diagnostic and Laboratory Facilities
7.1.5.1. Clinical Laboratories
7.1.5.2. Pathology Laboratories
7.1.5.3. Blood-Collection Centers
7.1.5.4. Point-of-Care Diagnostic Facilities

7.1.6. Dialysis, Infusion and Specialty Treatment Centers
7.1.6.1. Dialysis Centers
7.1.6.2. Infusion Centers
7.1.6.3. Wound-Care Centers
7.1.6.4. Oncology Treatment Centers

7.1.7. Home Healthcare and Long-Term Care
7.1.7.1. Home Healthcare Providers
7.1.7.2. Skilled Nursing Facilities
7.1.7.3. Assisted Living Facilities
7.1.7.4. Direct-to-Patient Supply Channels

What this section provides: This section evaluates purchasing and consumption patterns across U.S. care settings and identifies where disposable medical device demand is migrating as procedures shift toward outpatient, specialty, long-term, and home-based environments.

8. U.S. Disposable Medical Devices Market – By Material Type

8.1. Overview
8.1.1. Segment Share Analysis, By Material Type, 2025 & 2035 (%)

8.1.2. Plastics and Medical-Grade Polymers
8.1.2.1. Polypropylene
8.1.2.2. Polyethylene
8.1.2.3. Polyvinyl Chloride
8.1.2.4. Polyurethane
8.1.2.5. Polycarbonate
8.1.2.6. Other Medical-Grade Polymers

8.1.3. Nonwoven and Textile Materials
8.1.3.1. Spunbond Materials
8.1.3.2. Meltblown Materials
8.1.3.3. SMS and Composite Nonwovens
8.1.3.4. Medical Textiles

8.1.4. Rubber and Elastomers
8.1.4.1. Nitrile
8.1.4.2. Natural Rubber Latex
8.1.4.3. Silicone
8.1.4.4. Thermoplastic Elastomers

8.1.5. Paper, Cellulose and Absorbent Materials
8.1.5.1. Medical-Grade Paper
8.1.5.2. Cellulose-Based Absorbents
8.1.5.3. Sterilization and Barrier Materials

8.1.6. Metals, Composites and Other Materials
8.1.6.1. Stainless Steel
8.1.6.2. Conductive Materials
8.1.6.3. Multimaterial Composites
8.1.6.4. Other Specialty Materials

What this section provides: This section evaluates the material technologies underpinning disposable medical devices, including cost, availability, performance, sterilization compatibility, supply-chain exposure, and emerging sustainability considerations.

9. U.S. Disposable Medical Devices Market – By Geography
9.1. Introduction

9.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
9.1.3. Regional Hospital, ASC and Care Infrastructure Analysis
9.1.4. Regional Procedure and Patient Utilization Analysis
9.1.5. Regional Chronic Disease and Demographic Demand Analysis
9.1.6. Regional Procurement and GPO Dynamics
9.1.7. Regional Distribution and Supply-Chain Analysis

9.2. West Region

9.2.1. Regional Overview & Trends
9.2.2. West Region Key Manufacturers, Distributors and Procurement Ecosystem
9.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.7. West Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.8. West Region Procurement, Distribution and Supply-Chain Dynamics

9.2.9. California

9.2.9.1. Overview & Market Dynamics
9.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.9.5. California Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.9.6. Procurement, Distribution and Supply-Chain Analysis

9.2.10. Washington

9.2.10.1. Overview & Market Dynamics
9.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.10.5. Washington Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.10.6. Procurement, Distribution and Supply-Chain Analysis

9.2.11. Arizona

9.2.11.1. Overview & Market Dynamics
9.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.11.5. Arizona Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.11.6. Procurement, Distribution and Supply-Chain Analysis

9.2.12. Colorado

9.2.12.1. Overview & Market Dynamics
9.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.12.5. Colorado Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.12.6. Procurement, Distribution and Supply-Chain Analysis

9.2.13. Oregon

9.2.13.1. Overview & Market Dynamics
9.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.13.5. Oregon Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.13.6. Procurement, Distribution and Supply-Chain Analysis

9.2.14. Utah

9.2.14.1. Overview & Market Dynamics
9.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.14.5. Utah Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.14.6. Procurement, Distribution and Supply-Chain Analysis

9.2.15. Nevada

9.2.15.1. Overview & Market Dynamics
9.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.15.5. Nevada Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.15.6. Procurement, Distribution and Supply-Chain Analysis

9.2.16. New Mexico

9.2.16.1. Overview & Market Dynamics
9.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.16.5. New Mexico Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.16.6. Procurement, Distribution and Supply-Chain Analysis

9.2.17. Idaho

9.2.17.1. Overview & Market Dynamics
9.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.17.5. Idaho Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.17.6. Procurement, Distribution and Supply-Chain Analysis

9.2.18. Montana

9.2.18.1. Overview & Market Dynamics
9.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.18.5. Montana Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.18.6. Procurement, Distribution and Supply-Chain Analysis

9.2.19. Wyoming

9.2.19.1. Overview & Market Dynamics
9.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.19.5. Wyoming Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.19.6. Procurement, Distribution and Supply-Chain Analysis

9.2.20. Alaska

9.2.20.1. Overview & Market Dynamics
9.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.20.5. Alaska Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.20.6. Procurement, Distribution and Supply-Chain Analysis

9.2.21. Hawaii

9.2.21.1. Overview & Market Dynamics
9.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.2.21.5. Hawaii Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.2.21.6. Procurement, Distribution and Supply-Chain Analysis

9.3. Northeast Region

9.3.1. Regional Overview & Trends
9.3.2. Northeast Region Key Manufacturers, Distributors and Procurement Ecosystem
9.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.7. Northeast Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.8. Northeast Region Procurement, Distribution and Supply-Chain Dynamics

9.3.9. New York

9.3.9.1. Overview & Market Dynamics
9.3.9.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.9.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.9.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.9.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.9.6. Procurement, Distribution and Supply-Chain Analysis

9.3.10. Massachusetts

9.3.10.1. Overview & Market Dynamics
9.3.10.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.10.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.10.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.10.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.10.6. Procurement, Distribution and Supply-Chain Analysis

9.3.11. New Jersey

9.3.11.1. Overview & Market Dynamics
9.3.11.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.11.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.11.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.11.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.11.6. Procurement, Distribution and Supply-Chain Analysis

9.3.12. Pennsylvania

9.3.12.1. Overview & Market Dynamics
9.3.12.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.12.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.12.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.12.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.12.6. Procurement, Distribution and Supply-Chain Analysis

9.3.13. Connecticut

9.3.13.1. Overview & Market Dynamics
9.3.13.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.13.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.13.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.13.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.13.6. Procurement, Distribution and Supply-Chain Analysis

9.3.14. Maine

9.3.14.1. Overview & Market Dynamics
9.3.14.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.14.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.14.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.14.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.14.6. Procurement, Distribution and Supply-Chain Analysis

9.3.15. Vermont

9.3.15.1. Overview & Market Dynamics
9.3.15.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.15.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.15.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.15.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.15.6. Procurement, Distribution and Supply-Chain Analysis

9.3.16. New Hampshire

9.3.16.1. Overview & Market Dynamics
9.3.16.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.16.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.16.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.16.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.16.6. Procurement, Distribution and Supply-Chain Analysis

9.3.17. Rhode Island

9.3.17.1. Overview & Market Dynamics
9.3.17.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.17.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.17.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.17.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.17.6. Procurement, Distribution and Supply-Chain Analysis

9.3.18. Delaware

9.3.18.1. Overview & Market Dynamics
9.3.18.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.3.18.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.3.18.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.3.18.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.3.18.6. Procurement, Distribution and Supply-Chain Analysis

9.4. South Region

9.4.1. Regional Overview & Trends
9.4.2. South Region Key Manufacturers, Distributors and Procurement Ecosystem
9.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.7. South Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.8. South Region Procurement, Distribution and Supply-Chain Dynamics

9.4.9. Texas

9.4.9.1. Overview & Market Dynamics
9.4.9.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.9.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.9.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.9.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.9.6. Procurement, Distribution and Supply-Chain Analysis

9.4.10. Florida

9.4.10.1. Overview & Market Dynamics
9.4.10.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.10.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.10.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.10.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.10.6. Procurement, Distribution and Supply-Chain Analysis

9.4.11. Georgia

9.4.11.1. Overview & Market Dynamics
9.4.11.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.11.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.11.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.11.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.11.6. Procurement, Distribution and Supply-Chain Analysis

9.4.12. North Carolina

9.4.12.1. Overview & Market Dynamics
9.4.12.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.12.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.12.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.12.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.12.6. Procurement, Distribution and Supply-Chain Analysis

9.4.13. Tennessee

9.4.13.1. Overview & Market Dynamics
9.4.13.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.13.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.13.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.13.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.13.6. Procurement, Distribution and Supply-Chain Analysis

9.4.14. South Carolina

9.4.14.1. Overview & Market Dynamics
9.4.14.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.14.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.14.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.14.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.14.6. Procurement, Distribution and Supply-Chain Analysis

9.4.15. Alabama

9.4.15.1. Overview & Market Dynamics
9.4.15.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.15.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.15.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.15.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.15.6. Procurement, Distribution and Supply-Chain Analysis

9.4.16. Mississippi

9.4.16.1. Overview & Market Dynamics
9.4.16.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.16.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.16.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.16.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.16.6. Procurement, Distribution and Supply-Chain Analysis

9.4.17. Louisiana

9.4.17.1. Overview & Market Dynamics
9.4.17.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.17.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.17.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.17.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.17.6. Procurement, Distribution and Supply-Chain Analysis

9.4.18. Arkansas

9.4.18.1. Overview & Market Dynamics
9.4.18.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.18.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.18.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.18.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.18.6. Procurement, Distribution and Supply-Chain Analysis

9.4.19. Kentucky

9.4.19.1. Overview & Market Dynamics
9.4.19.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.19.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.19.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.19.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.19.6. Procurement, Distribution and Supply-Chain Analysis

9.4.20. Oklahoma

9.4.20.1. Overview & Market Dynamics
9.4.20.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.20.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.20.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.20.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.20.6. Procurement, Distribution and Supply-Chain Analysis

9.4.21. Virginia

9.4.21.1. Overview & Market Dynamics
9.4.21.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.21.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.21.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.21.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.21.6. Procurement, Distribution and Supply-Chain Analysis

9.4.22. Maryland

9.4.22.1. Overview & Market Dynamics
9.4.22.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.22.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.22.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.22.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.22.6. Procurement, Distribution and Supply-Chain Analysis

9.4.23. West Virginia

9.4.23.1. Overview & Market Dynamics
9.4.23.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.4.23.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.4.23.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.4.23.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.4.23.6. Procurement, Distribution and Supply-Chain Analysis

9.5. Midwest Region

9.5.1. Regional Overview & Trends
9.5.2. Midwest Region Key Manufacturers, Distributors and Procurement Ecosystem
9.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
9.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.7. Midwest Region Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.8. Midwest Region Procurement, Distribution and Supply-Chain Dynamics

9.5.9. Illinois

9.5.9.1. Overview & Market Dynamics
9.5.9.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.9.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.9.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.9.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.9.6. Procurement, Distribution and Supply-Chain Analysis

9.5.10. Ohio

9.5.10.1. Overview & Market Dynamics
9.5.10.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.10.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.10.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.10.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.10.6. Procurement, Distribution and Supply-Chain Analysis

9.5.11. Michigan

9.5.11.1. Overview & Market Dynamics
9.5.11.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.11.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.11.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.11.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.11.6. Procurement, Distribution and Supply-Chain Analysis

9.5.12. Minnesota

9.5.12.1. Overview & Market Dynamics
9.5.12.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.12.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.12.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.12.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.12.6. Procurement, Distribution and Supply-Chain Analysis

9.5.13. Indiana

9.5.13.1. Overview & Market Dynamics
9.5.13.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.13.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.13.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.13.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.13.6. Procurement, Distribution and Supply-Chain Analysis

9.5.14. Wisconsin

9.5.14.1. Overview & Market Dynamics
9.5.14.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.14.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.14.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.14.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.14.6. Procurement, Distribution and Supply-Chain Analysis

9.5.15. Missouri

9.5.15.1. Overview & Market Dynamics
9.5.15.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.15.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.15.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.15.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.15.6. Procurement, Distribution and Supply-Chain Analysis

9.5.16. Iowa

9.5.16.1. Overview & Market Dynamics
9.5.16.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.16.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.16.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.16.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.16.6. Procurement, Distribution and Supply-Chain Analysis

9.5.17. Kansas

9.5.17.1. Overview & Market Dynamics
9.5.17.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.17.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.17.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.17.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.17.6. Procurement, Distribution and Supply-Chain Analysis

9.5.18. Nebraska

9.5.18.1. Overview & Market Dynamics
9.5.18.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.18.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.18.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.18.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.18.6. Procurement, Distribution and Supply-Chain Analysis

9.5.19. North Dakota

9.5.19.1. Overview & Market Dynamics
9.5.19.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.19.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.19.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.19.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.19.6. Procurement, Distribution and Supply-Chain Analysis

9.5.20. South Dakota

9.5.20.1. Overview & Market Dynamics
9.5.20.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
9.5.20.3. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
9.5.20.4. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
9.5.20.5. Market Size and Forecast, By Material Type, 2021–2035 (US$ Billion)
9.5.20.6. Procurement, Distribution and Supply-Chain Analysis

What this section provides: This section delivers detailed regional and state-level intelligence across all 50 U.S. states, helping clients identify high-consumption markets, hospital and ASC hubs, chronic-care demand pockets, supply-chain requirements, procurement environments, and state-level commercial opportunities.

10. U.S. Disposable Medical Devices Market: Competitive Landscape & Company Profiles

10.1. Market Share Analysis, 2025
10.2. Competitive Benchmarking
10.2.1. Portfolio Breadth
10.2.2. U.S. Distribution Reach
10.2.3. Hospital and GPO Contracting Strength
10.2.4. Product Innovation
10.2.5. Manufacturing and Supply Resilience
10.2.6. Home-Care and Direct-to-Patient Capabilities

10.3. Company Positioning Matrix
10.3.1. Leaders
10.3.2. Challengers
10.3.3. Innovators
10.3.4. Emerging and Specialized Players

10.4. Company Profiles

10.4.1. Medline Industries
10.4.2. Cardinal Health
10.4.3. Becton, Dickinson and Company
10.4.4. Baxter International
10.4.5. B. Braun
10.4.6. Terumo Corporation
10.4.7. Teleflex Incorporated
10.4.8. ICU Medical
10.4.9. Solventum Corporation
10.4.10. Smith+Nephew
10.4.11. Convatec Group
10.4.12. Coloplast
10.4.13. Hollister Incorporated
10.4.14. Mölnlycke Health Care
10.4.15. Owens & Minor
10.4.16. Ansell
10.4.17. Avanos Medical
10.4.18. McKesson Corporation
10.4.19. Nipro Corporation
10.4.20. Fresenius Medical Care
10.4.21. Merit Medical Systems
10.4.22. Cook Medical
10.4.23. Boston Scientific Corporation
10.4.24. Johnson & Johnson MedTech
10.4.25. Stryker Corporation

10.5. Company Profile Framework
10.5.1. Company Overview
10.5.2. Disposable Medical Device Portfolio
10.5.3. U.S. Market Presence and Strategy
10.5.4. Manufacturing and Distribution Footprint
10.5.5. Financial and Competitive Positioning
10.5.6. Product Innovation Pipeline
10.5.7. FDA and Regulatory Developments
10.5.8. Partnerships, M&A and Capacity Expansion
10.5.9. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, product portfolio positioning, distribution reach, manufacturing strength, innovation direction, and strategic intelligence on 25 major participants in the U.S. disposable medical devices market.

11. U.S. Disposable Medical Devices Market: Future Market Outlook, 2026–2035

11.1. Scenario Analysis
11.1.1. Optimistic Scenario
11.1.2. Realistic Scenario
11.1.3. Pessimistic Scenario

11.2. Disruptive Technologies Impact
11.2.1. Safety-Engineered Injection and Needleless Systems
11.2.2. Closed-System Infusion and Vascular Access Technologies
11.2.3. Customized and Preconfigured Procedure Packs
11.2.4. Advanced Disposable Wound-Care Technologies
11.2.5. Disposable Negative-Pressure Wound Therapy
11.2.6. Single-Use Minimally Invasive Procedure Accessories
11.2.7. Sustainable and Reduced-Material Device Designs
11.2.8. RFID, UDI and Smart Inventory Technologies
11.2.9. Automated Direct-to-Patient Fulfillment

11.3. Outpatient Procedure Migration Outlook
11.4. Home Healthcare and Chronic-Care Consumption Outlook
11.5. Domestic Manufacturing and Supply-Security Outlook
11.6. Sustainability and Circular-Economy Impact
11.7. Single-Use Versus Reusable Device Economics
11.8. Reprocessed Single-Use Device Impact
11.9. Emerging Business Trends
11.10. Business Opportunities for Startups and Existing Players
11.11. Investment Prioritization Matrix
11.12. High-Growth Product Opportunity Matrix
11.13. State and Regional Expansion Opportunity Matrix

What this section provides: This section prepares clients for changes in technology, care settings, sourcing, environmental requirements, market structure, product economics, and investment opportunities that could reshape the U.S. disposable medical devices market through 2035.

12. U.S. Disposable Medical Devices Market: Strategic Recommendations

12.1. Recommendations for Disposable Medical Device Manufacturers
12.2. Recommendations for Hospitals and Integrated Delivery Networks
12.3. Recommendations for Ambulatory Surgery Centers
12.4. Recommendations for Home Healthcare and Long-Term Care Providers
12.5. Recommendations for Investors and Private Equity Firms
12.6. Recommendations for GPOs and Procurement Organizations
12.7. Recommendations for Distributors and Channel Partners
12.8. Recommendations for New Entrants and Startups
12.9. Domestic Manufacturing and Supply-Chain Diversification Strategy
12.10. Go-to-Market Strategy Considerations
12.11. Hospital Contracting and Value-Analysis Strategy
12.12. ASC and Outpatient Channel Expansion Strategy
12.13. Direct-to-Patient Commercialization Strategy
12.14. Product Positioning and Portfolio Expansion Guidance
12.15. Pricing and Premium-Differentiation Strategy
12.16. Sustainability and Packaging Optimization Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, pricing, hospital contracting, channel expansion, manufacturing strategy, portfolio positioning, investment planning, and competitive differentiation.

13. U.S. Disposable Medical Devices Market: Disclaimer

13.1. Scope Limitation
13.2. Market Definition Limitation
13.3. Data Use Limitation
13.4. Historical Data Limitation
13.5. Forecasting Limitation
13.6. State-Level Estimation Limitation
13.7. Company and Competitive Intelligence Limitation
13.8. Regulatory and Reimbursement Information Disclaimer
13.9. Legal Disclaimer
13.10. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s analytical boundaries, market-sizing limitations, forecast assumptions, state-level estimation methodology, regulatory considerations, legal limitations, and permitted interpretation of market intelligence.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Disposable Medical Devices Market: Market Definition and Scope
TABLE 3: U.S. Disposable Medical Devices Market: Research Methodology Framework
TABLE 4: U.S. Disposable Medical Devices Market: Market Sizing and Forecasting Framework
TABLE 5: U.S. Disposable Medical Devices Market: Key Assumptions
TABLE 6: U.S. Disposable Medical Devices Market: Market Ecosystem and Stakeholder Analysis
TABLE 7: U.S. Disposable Medical Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Disposable Medical Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Disposable Medical Devices Market: Market Attractiveness Index
TABLE 10: U.S. Disposable Medical Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Disposable Medical Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Disposable Medical Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Disposable Medical Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Disposable Medical Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Disposable Medical Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Disposable Medical Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Disposable Medical Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Disposable Medical Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Disposable Medical Devices Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Disposable Medical Devices Market: Procedure-Level Consumable Economics
TABLE 21: U.S. Disposable Medical Devices Market: Hospital Procurement Behavior Matrix
TABLE 22: U.S. Disposable Medical Devices Market: Value Analysis Committee Decision Framework
TABLE 23: U.S. Disposable Medical Devices Market: ASC Purchasing Economics
TABLE 24: U.S. Disposable Medical Devices Market: Home Healthcare Replenishment Economics
TABLE 25: U.S. Disposable Medical Devices Market: PESTEL Analysis
TABLE 26: U.S. Disposable Medical Devices Market: Porter’s Five Forces Analysis
TABLE 27: U.S. Disposable Medical Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 28: U.S. Disposable Medical Devices Market: Value Chain Analysis
TABLE 29: U.S. Disposable Medical Devices Market: Supply Chain Analysis
TABLE 30: U.S. Disposable Medical Devices Market: Raw Material Availability and Cost Analysis
TABLE 31: U.S. Disposable Medical Devices Market: Medical-Grade Polymer Supply Landscape
TABLE 32: U.S. Disposable Medical Devices Market: Medical Nonwoven Supply Landscape
TABLE 33: U.S. Disposable Medical Devices Market: Sterilization and Packaging Landscape
TABLE 34: U.S. Disposable Medical Devices Market: UDI and Inventory Digitalization Analysis
TABLE 35: U.S. Disposable Medical Devices Market: Application & Innovation Landscape
TABLE 36: U.S. Disposable Medical Devices Market: FDA Regulatory Framework Analysis
TABLE 37: U.S. Disposable Medical Devices Market: Reprocessed Single-Use Device Regulatory Landscape
TABLE 38: U.S. Disposable Medical Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 39: U.S. Disposable Medical Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 40: U.S. Disposable Medical Devices Market: Domestic Manufacturing and Supply-Security Initiatives
TABLE 41: U.S. Disposable Medical Devices Market: Environmental Sustainability and Medical Waste Analysis
TABLE 42: U.S. Disposable Medical Devices Market: Geopolitical and Supply-Chain Risk Analysis
TABLE 43: U.S. Disposable Medical Devices Market: GPO and IDN Contracting Environment
TABLE 44: U.S. Disposable Medical Devices Market: Product Category Snapshot, 2025
TABLE 45: Segment Dashboard; Definition and Scope, by Product Category
TABLE 46: U.S. Disposable Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 47: U.S. Disposable Medical Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 48: Surgical and Procedure Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Injection and Infusion Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Infection-Control and Protective Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Diagnostic and Specimen-Collection Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Wound-Care Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Respiratory and Anesthesia Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Urological and Continence Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: Dialysis and Blood-Management Disposables Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: Other Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Disposable Medical Devices Market: Application Snapshot, 2025
TABLE 58: Segment Dashboard; Definition and Scope, by Application
TABLE 59: U.S. Disposable Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 60: U.S. Disposable Medical Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 61: Surgical and Perioperative Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Chronic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Diagnostic and Testing Procedures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Infection Prevention and General Patient Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: Critical Care, Emergency and Respiratory Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Renal and Urological Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Disposable Medical Devices Market: End User Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by End User
TABLE 69: U.S. Disposable Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 70: U.S. Disposable Medical Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 71: Hospitals and Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Diagnostic and Laboratory Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: Dialysis, Infusion and Specialty Treatment Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Home Healthcare and Long-Term Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Disposable Medical Devices Market: Material Type Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Material Type
TABLE 79: U.S. Disposable Medical Devices Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 80: U.S. Disposable Medical Devices Market: Segment Share Analysis, by Material Type, 2025 & 2035 (%)
TABLE 81: Plastics and Medical-Grade Polymers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Nonwoven and Textile Materials Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: Rubber and Elastomers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: Paper, Cellulose and Absorbent Materials Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: Metals, Composites and Other Materials Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Disposable Medical Devices Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Geography
TABLE 88: U.S. Disposable Medical Devices Market, by Geography, 2021–2035 (US$ Billion)
TABLE 89: U.S. Disposable Medical Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: West Region U.S. Disposable Medical Devices Market: Regional Overview and Trends
TABLE 91: West Region U.S. Disposable Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Disposable Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Disposable Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Disposable Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Disposable Medical Devices Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 96: California Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Washington Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Arizona Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Colorado Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Oregon Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Utah Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Nevada Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: New Mexico Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Idaho Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Montana Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Wyoming Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Alaska Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Hawaii Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Disposable Medical Devices Market: Regional Overview and Trends
TABLE 110: Northeast Region U.S. Disposable Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 111: Northeast Region U.S. Disposable Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 112: Northeast Region U.S. Disposable Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 113: Northeast Region U.S. Disposable Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 114: Northeast Region U.S. Disposable Medical Devices Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 115: New York Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Massachusetts Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: New Jersey Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Pennsylvania Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Connecticut Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: Maine Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 121: Vermont Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 122: New Hampshire Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 123: Rhode Island Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Delaware Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: South Region U.S. Disposable Medical Devices Market: Regional Overview and Trends
TABLE 126: South Region U.S. Disposable Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 127: South Region U.S. Disposable Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 128: South Region U.S. Disposable Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 129: South Region U.S. Disposable Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 130: South Region U.S. Disposable Medical Devices Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 131: Texas Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Florida Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Georgia Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: North Carolina Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Tennessee Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: South Carolina Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Alabama Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Mississippi Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: Louisiana Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Arkansas Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 141: Kentucky Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 142: Oklahoma Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Virginia Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Maryland Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: West Virginia Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Midwest Region U.S. Disposable Medical Devices Market: Regional Overview and Trends
TABLE 147: Midwest Region U.S. Disposable Medical Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 148: Midwest Region U.S. Disposable Medical Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 149: Midwest Region U.S. Disposable Medical Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 150: Midwest Region U.S. Disposable Medical Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 151: Midwest Region U.S. Disposable Medical Devices Market, by Material Type, 2021–2035 (US$ Billion)
TABLE 152: Illinois Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Ohio Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Michigan Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Minnesota Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Indiana Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Wisconsin Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: Missouri Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Iowa Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 160: Kansas Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 161: Nebraska Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 162: North Dakota Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 163: South Dakota Disposable Medical Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 164: U.S. Disposable Medical Devices Market: Competitive Landscape Snapshot, 2025
TABLE 165: U.S. Disposable Medical Devices Market: Key Company Market Share Analysis, 2025
TABLE 166: U.S. Disposable Medical Devices Market: Company Positioning Matrix
TABLE 167: U.S. Disposable Medical Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 168: U.S. Disposable Medical Devices Market: Manufacturing, Distribution and Supply Resilience Benchmarking
TABLE 169: U.S. Disposable Medical Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 170: Medline Industries: Company Profile
TABLE 171: Cardinal Health: Company Profile
TABLE 172: Becton, Dickinson and Company: Company Profile
TABLE 173: Baxter International: Company Profile
TABLE 174: B. Braun: Company Profile
TABLE 175: Terumo Corporation: Company Profile
TABLE 176: Teleflex Incorporated: Company Profile
TABLE 177: ICU Medical: Company Profile
TABLE 178: Solventum Corporation: Company Profile
TABLE 179: Smith+Nephew: Company Profile
TABLE 180: Convatec Group: Company Profile
TABLE 181: Coloplast: Company Profile
TABLE 182: Hollister Incorporated: Company Profile
TABLE 183: Mölnlycke Health Care: Company Profile
TABLE 184: Owens & Minor: Company Profile
TABLE 185: Ansell: Company Profile
TABLE 186: Avanos Medical: Company Profile
TABLE 187: McKesson Corporation: Company Profile
TABLE 188: Nipro Corporation: Company Profile
TABLE 189: Fresenius Medical Care: Company Profile
TABLE 190: Merit Medical Systems: Company Profile
TABLE 191: Cook Medical: Company Profile
TABLE 192: Boston Scientific Corporation: Company Profile
TABLE 193: Johnson & Johnson MedTech: Company Profile
TABLE 194: Stryker Corporation: Company Profile
TABLE 195: U.S. Disposable Medical Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 196: U.S. Disposable Medical Devices Market: Disruptive Technologies Impact Matrix
TABLE 197: U.S. Disposable Medical Devices Market: Outpatient Procedure Migration Outlook
TABLE 198: U.S. Disposable Medical Devices Market: Home Healthcare Consumption Outlook
TABLE 199: U.S. Disposable Medical Devices Market: Domestic Manufacturing and Supply-Security Outlook
TABLE 200: U.S. Disposable Medical Devices Market: Single-Use vs. Reusable Device Economics
TABLE 201: U.S. Disposable Medical Devices Market: Reprocessed Single-Use Device Impact
TABLE 202: U.S. Disposable Medical Devices Market: Investment Prioritization Matrix
TABLE 203: U.S. Disposable Medical Devices Market: Strategic Recommendations for Manufacturers
TABLE 204: U.S. Disposable Medical Devices Market: Strategic Recommendations for Hospitals and IDNs
TABLE 205: U.S. Disposable Medical Devices Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 206: U.S. Disposable Medical Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 207: U.S. Disposable Medical Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 208: U.S. Disposable Medical Devices Market: Go-to-Market Strategy Considerations
TABLE 209: U.S. Disposable Medical Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 210: U.S. Disposable Medical Devices Market: Scope and Market Definition Limitation
TABLE 211: U.S. Disposable Medical Devices Market: Data Use and Historical Data Limitation
TABLE 212: U.S. Disposable Medical Devices Market: Forecasting and State-Level Estimation Limitation
TABLE 213: U.S. Disposable Medical Devices Market: Regulatory and Legal Disclaimer
TABLE 214: U.S. Disposable Medical Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Disposable Medical Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Sizing and Forecasting Framework
FIGURE 4: Market Ecosystem and Stakeholder Landscape
FIGURE 5: U.S. Disposable Medical Devices Market Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 6: U.S. Disposable Medical Devices Market Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Disposable Medical Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Consumables Procurement Decision Framework
FIGURE 13: ASC Purchasing Economics Framework
FIGURE 14: Home Healthcare Replenishment Model
FIGURE 15: PESTEL Analysis
FIGURE 16: Porter’s Five Forces Analysis
FIGURE 17: Value Chain Analysis
FIGURE 18: Supply Chain Analysis
FIGURE 19: Medical-Grade Raw Material Supply Landscape
FIGURE 20: Sterilization and Packaging Ecosystem
FIGURE 21: UDI and Digital Inventory Management Framework
FIGURE 22: FDA Regulatory Framework for Disposable Medical Devices
FIGURE 23: Sustainability and Medical Waste Management Framework
FIGURE 24: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Surgical and Procedure Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 27: Injection and Infusion Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 28: Infection-Control and Protective Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 29: Diagnostic and Specimen-Collection Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 30: Wound-Care Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 31: Respiratory and Anesthesia Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 32: Urological and Continence Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 33: Dialysis and Blood-Management Disposables Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 34: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Surgical and Perioperative Care Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 37: Chronic Disease Management Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 38: Diagnostic and Testing Procedures Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 39: Infection Prevention and General Patient Care Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 40: Critical Care, Emergency and Respiratory Management Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 41: Renal and Urological Care Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 42: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 43: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Hospitals and Health Systems Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 45: Ambulatory Surgery Centers Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 46: Clinics and Physician Practices Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 47: Diagnostic and Laboratory Facilities Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 48: Dialysis, Infusion and Specialty Treatment Centers Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 49: Home Healthcare and Long-Term Care Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 50: Material Type Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Material Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Plastics and Medical-Grade Polymers Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 53: Nonwoven and Textile Materials Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 54: Rubber and Elastomers Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 55: Paper, Cellulose and Absorbent Materials Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 56: Metals, Composites and Other Materials Market Size Forecast, 2021–2035 (US$ Billion)
FIGURE 57: Regional Market Share Analysis, 2025 & 2035
FIGURE 58: Regional Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: West Region Market Share Analysis by State, 2025
FIGURE 60: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: California Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 62: Washington Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 63: Arizona Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 64: Colorado Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 65: Oregon Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 66: Utah Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 67: Nevada Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 68: New Mexico Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 69: Idaho Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 70: Montana Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 71: Wyoming Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 72: Alaska Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 73: Hawaii Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 74: Northeast Region Market Share Analysis by State, 2025
FIGURE 75: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: New York Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 77: Massachusetts Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 78: New Jersey Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 79: Pennsylvania Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 80: Connecticut Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 81: Maine Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 82: Vermont Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 83: New Hampshire Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 84: Rhode Island Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 85: Delaware Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 89: Florida Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 90: Georgia Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 91: North Carolina Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 92: Tennessee Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 93: South Carolina Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 94: Alabama Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 95: Mississippi Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 96: Louisiana Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 97: Arkansas Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 98: Kentucky Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 99: Oklahoma Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 100: Virginia Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 101: Maryland Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 102: West Virginia Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 103: Midwest Region Market Share Analysis by State, 2025
FIGURE 104: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Illinois Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 106: Ohio Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 107: Michigan Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 108: Minnesota Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 109: Indiana Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 110: Wisconsin Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 111: Missouri Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 112: Iowa Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 113: Kansas Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 114: Nebraska Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 115: North Dakota Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 116: South Dakota Disposable Medical Devices Market Size and Trend Analysis, 2021–2035
FIGURE 117: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 118: Company Positioning Matrix
FIGURE 119: Key Player Product Portfolio Benchmarking
FIGURE 120: Manufacturing, Distribution and Supply Resilience Benchmarking
FIGURE 121: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 122: Disposable Medical Devices Innovation Roadmap
FIGURE 123: Safety-Engineered Injection and Vascular Access Adoption Roadmap
FIGURE 124: Customized Procedure Pack Opportunity Map
FIGURE 125: Advanced Disposable Wound-Care Innovation Roadmap
FIGURE 126: Home Healthcare and Direct-to-Patient Growth Roadmap
FIGURE 127: Sustainable Disposable Medical Device Development Roadmap
FIGURE 128: Future Market Scenario Analysis, 2026–2035
FIGURE 129: Disruptive Technologies Impact Matrix
FIGURE 130: Outpatient Procedure Migration Outlook
FIGURE 131: Single-Use vs. Reusable Device Economics Framework
FIGURE 132: Reprocessed Single-Use Device Impact Framework
FIGURE 133: Emerging Business Trends Matrix
FIGURE 134: Investment Prioritization Matrix
FIGURE 135: Strategic Growth Roadmap for U.S. Disposable Medical Device Companies
FIGURE 136: Hospital and IDN Go-to-Market Strategy Framework
FIGURE 137: ASC and Outpatient Channel Expansion Framework
FIGURE 138: Direct-to-Patient Commercialization Framework
FIGURE 139: Product Positioning and Portfolio Expansion Framework
FIGURE 140: Sustainability and Packaging Optimization Framework
FIGURE 141: Report Scope, Forecasting and Disclaimer Framework